CARDARINE (GW502516)

Product Description

Cardarine, also known by its research code GW501516, is a PPARδ (Peroxisome Proliferator-Activated Receptor delta) receptor agonist developed in the 1990s by GlaxoSmithKline and Ligand Pharmaceuticals. Though often mistakenly grouped with SARMs (Selective Androgen Receptor Modulators), Cardarine is not a SARM. Instead, it targets different pathways in the body to enhance metabolism and endurance.

How It Works:

Cardarine binds to the PPARδ receptor, which influences the expression of genes involved in fat metabolism, glucose uptake, and energy expenditure. This action promotes the body’s use of fat as a primary energy source, potentially improving fat loss, endurance, and overall athletic performance.

Potential Benefits:

• Enhanced aerobic endurance and stamina

• Increased fat oxidation and reduced fat storage

• Improved glucose tolerance and insulin sensitivity

• Possible cardiovascular protective effects (based on early studies)